# EDGAR Filing Document

**Accession Number:** 0001761918
**File Stem:** 0001193125-25-184070
**Filing Date:** 2025-8
**Character Count:** 2257
**Document Hash:** 8e92f4827f38334fa978cfcedf3e7805
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-184070.hdr.sgml**: 20250922

**ACCESSION NUMBER**: 0001193125-25-184070

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250820

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Erasca, Inc.
- **CENTRAL INDEX KEY:** 0001761918
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 831217027
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3115 MERRYFIELD ROW
- **STREET 2:** THIRD FLOOR
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** (858) 465-6511

**MAIL ADDRESS:**
- **STREET 1:** 3115 MERRYFIELD ROW
- **STREET 2:** THIRD FLOOR
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

**Erasca, Inc.** 

**3115 Merryfield Row, Suite 300** 

**San Diego, CA 92121** 

August 20, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Erasca, Inc.**  |

---

**Registration Statement on Form S-3** 

**File No. 333-289537** 

To the addressees set forth above:

Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on August 22, 2025, or as soon as practicable thereafter.

If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| ERASCA, INC. | ERASCA, INC. |
| By: | /s/ Jonathan E. Lim |
|  | Jonathan E. Lim, M.D. |
|  | Chairman, Chief Executive Officer and Co-Founder |

---

cc: Ebun S. Garner, Erasca, Inc.

Cheston J. Larson, Latham & Watkins LLP

Matthew T. Bush, Latham & Watkins LLP